Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 1Other hematologic neoplasm 1Lymphoid 1CNS 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 128Lymphoma 107Lymphoma, Large B-Cell, Diffuse 96Leukemia 55Burkitt Lymphoma 50Lymphoma, Non-Hodgkin 49Lymphoma, Follicular 37Lymphoma, Mantle-Cell 33Hodgkin Disease 25Retinoblastoma 16Recurrence 16Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 16Lymphoma, T-Cell, Peripheral 16Lymphoma, Large-Cell, Anaplastic 16Central Nervous System Neoplasms 16Neuroblastoma 15Lymphoma, Large-Cell, Immunoblastic 15Lymphoma, B-Cell 15Sarcoma 13Rhabdomyosarcoma 12Lymphoma, B-Cell, Marginal Zone 12Neoplasms 11Medulloblastoma 11Immunoblastic Lymphadenopathy 11Sarcoma, Ewing 10Lymphoma, T-Cell 10Leukemia, Lymphocytic, Chronic, B-Cell 9Leukemia, Biphenotypic, Acute 8Dendritic Cell Sarcoma, Interdigitating 8Enteropathy-Associated T-Cell Lymphoma 7

Interventions

Cisplatin 7Etoposide 6Amifostine 6Radiotherapy 5Drug Therapy 5Cyclophosphamide 5apatinib 4Methotrexate 4Filgrastim 4Cytarabine 4sodium thiosulfate 3Methylprednisolone 3Carboplatin 3pegfilgrastim 2glucarpidase 2etoposide phosphate 2Voriconazole 2Vincristine 2Social Determinants of Health 2Pyridoxine 2Nivolumab 2Gemcitabine 2Doxorubicin 2Docetaxel 2Chemotherapy, Adjuvant 2Capecitabine 2trastuzumab deruxtecan 1selinexor 1sargramostim 1sacituzumab govitecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Drug-Related Side Effects and Adverse Reactions × Vincristine × Clear all
NCT00400946 2026-02-13

05-001: Treatment of Acute Lymphoblastic Leukemia in Children

Dana-Farber Cancer Institute

Phase 3 Completed
800 enrolled 22 charts
LymphoidOther hematologic neoplasm

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Drug-Related Side Effects and Adverse Reactions

NCT00005796 2015-03-25

Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors

Indiana University

Phase 1 Completed
10 enrolled
CNSSarcoma

Familial ependymoma, Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡